These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34322877)

  • 1. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment.
    Yang X; Guo Y; Chen C; Shao B; Zhao L; Zhou Q; Liu J; Wang G; Yuan W; Sun Z
    Immunology; 2021 Nov; 164(3):476-493. PubMed ID: 34322877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
    Hack SP; Zhu AX; Wang Y
    Front Immunol; 2020; 11():598877. PubMed ID: 33250900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.
    Morrissey SM; Yan J
    Trends Cancer; 2020 Jul; 6(7):550-558. PubMed ID: 32610067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
    Murayama M; Hosonuma M; Kuramasu A; Kobayashi S; Sasaki A; Baba Y; Narikawa Y; Toyoda H; Isobe J; Funayama E; Tajima K; Sasaki A; Maruyama Y; Yamazaki Y; Shida M; Hamada K; Hirasawa Y; Tsurui T; Ariizumi H; Ishiguro T; Suzuki R; Ohkuma R; Kubota Y; Horiike A; Sambe T; Tsuji M; Wada S; Kobayashi S; Shimane T; Tsunoda T; Kobayashi H; Kiuchi Y; Yoshimura K
    Sci Rep; 2024 May; 14(1):11325. PubMed ID: 38760458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the tumour microenvironment.
    Laplane L; Duluc D; Bikfalvi A; Larmonier N; Pradeu T
    Int J Cancer; 2019 Nov; 145(10):2611-2618. PubMed ID: 30989643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer.
    Overacre-Delgoffe AE; Bumgarner HJ; Cillo AR; Burr AHP; Tometich JT; Bhattacharjee A; Bruno TC; Vignali DAA; Hand TW
    Immunity; 2021 Dec; 54(12):2812-2824.e4. PubMed ID: 34861182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
    Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer.
    Lyu X; Wang P; Qiao Q; Jiang Y
    BMC Cancer; 2021 May; 21(1):646. PubMed ID: 34059019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
    Hayase E; Jenq RR
    Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the gut microbiota on immune cell interactions and cancer treatment.
    Liu C; Fu L; Wang Y; Yang W
    J Transl Med; 2024 Oct; 22(1):939. PubMed ID: 39407240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
    Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
    Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.
    Pérez-Ruiz E; Melero I; Kopecka J; Sarmento-Ribeiro AB; García-Aranda M; De Las Rivas J
    Drug Resist Updat; 2020 Dec; 53():100718. PubMed ID: 32736034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study.
    Ling Z; Shao L; Liu X; Cheng Y; Yan C; Mei Y; Ji F; Liu X
    Front Immunol; 2019; 10():533. PubMed ID: 30936882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.
    Zhang J; Dai Z; Yan C; Zhang W; Wang D; Tang D
    Clin Transl Oncol; 2021 Dec; 23(12):2415-2430. PubMed ID: 34125407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.
    Gao Y; Bi D; Xie R; Li M; Guo J; Liu H; Guo X; Fang J; Ding T; Zhu H; Cao Y; Xing M; Zheng J; Xu Q; Xu Q; Wei Q; Qin H
    Signal Transduct Target Ther; 2021 Nov; 6(1):398. PubMed ID: 34795206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.
    Zhang C; Liu Y
    Front Immunol; 2020; 11():1295. PubMed ID: 32714324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral microbial dysbiosis and its performance in predicting oral cancer.
    Su SC; Chang LC; Huang HD; Peng CY; Chuang CY; Chen YT; Lu MY; Chiu YW; Chen PY; Yang SF
    Carcinogenesis; 2021 Feb; 42(1):127-135. PubMed ID: 32621740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.